Skip to main content

Staxyn FDA Approval History

FDA Approved: Yes (First approved June 17, 2010)
Brand name: Staxyn
Generic name: vardenafil
Dosage form: Orally Disintegrating Tablets
Companies: GlaxoSmithKline, Merck
Treatment for: Erectile Dysfunction

Staxyn (vardenafil) is a phosphodiesterase type 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction.

Development timeline for Staxyn

Jun 18, 2010Approval FDA approves Staxyn (vardenafil HCl) orally disintegrating tablets for erectile dysfunction (ED)

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.